@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-DSTR114N-6
  skos:prefLabel "Isoxazoles"@fr, "Isoxazoles"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-KWRLGQ6C-4 .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-KWRLGQ6C-4
  mesh:allowableQualifier jvr:-HQRFT0C6-B, jvr:-WK5F724J-1, jvr:-NB0XHT3S-N, jvr:-T9HQD7ST-J, jvr:-R3QWLHRG-V, jvr:-W6SQV79N-S, jvr:-NKM836P1-M, jvr:-TJHVZCRZ-0, jvr:-CB30NGKB-3, jvr:-BT300B3G-Q, jvr:-G30ZJ446-J, jvr:-D0F21513-5, jvr:-THHNVC7V-3, jvr:-NFTHND7Q-8, jvr:-H7K65Q8S-Z, jvr:-Q3979798-W, jvr:-M63HSDM7-1, jvr:-FWD2BGQ0-9, jvr:-G4R176S9-J, jvr:-XV06LPML-W, jvr:-SBNWSM1T-R, jvr:-S0CS1X5R-5, jvr:-L6C0XPHT-4, jvr:-NHL3D2X0-S, jvr:-R0ZCQ8X6-J ;
  skos:inScheme jvr: ;
  skos:prefLabel "Isocarboxazide"@fr, "Isocarboxazid"@en ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D007520> ;
  skos:altLabel "3-Isoxazolecarboxylic acid, 5-methyl-, 2-(phenylmethyl)hydrazide"@fr, "3-Isoxazolecarboxylic acid, 5-methyl-, 2-(phenylmethyl)hydrazide"@en, "34237V843T"@fr, "34237V843T"@en, "59-63-2 (Isocarboxazid)"@en, "59-63-2 (Isocarboxazid)"@fr ;
  dc:established "1966-01-01"^^xsd:date ;
  dc:modified "2016-05-31"^^xsd:date ;
  mesh:pharmacologicalAction jvr:-C27HW0ZD-N, jvr:-RKGZF8PT-H ;
  a mesh:Descriptor, skos:Concept ;
  dc:created "1999-01-01"^^xsd:date ;
  skos:broader jvr:-DSTR114N-6 ;
  skos:definition "An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)"@en .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-C27HW0ZD-N
  skos:prefLabel "Monoamine Oxidase Inhibitors"@en, "Inhibiteurs de la monoamine oxydase"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-RKGZF8PT-H
  skos:prefLabel "Antidépresseurs"@fr, "Antidepressive Agents"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .